"Antilymphocyte Serum" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION.
Descriptor ID |
D000961
|
MeSH Number(s) |
A12.207.152.846.500.203 D12.776.124.486.485.114.573.203 D12.776.124.790.651.114.573.203 D12.776.377.715.548.114.573.203 D20.215.401.203
|
Concept/Terms |
Antilymphocyte Serum- Antilymphocyte Serum
- Antilymphocyte Serums
- Serum, Antilymphocyte
- Serums, Antilymphocyte
Antilymphocyte Globulin- Antilymphocyte Globulin
- Antilymphocyte Globulins
- Globulin, Antilymphocyte
- Globulins, Antilymphocyte
Antithymoglobulin- Antithymoglobulin
- Antithymoglobulins
- Antithymocyte Globulin
- Antithymocyte Globulins
- Globulin, Antithymocyte
- Globulins, Antithymocyte
- Lymphocyte Immune Globulin, Anti-Thymocyte Globulin
- Lymphocyte Immune Globulin, Anti Thymocyte Globulin
- Anti-Thymocyte Globulin
- Anti Thymocyte Globulin
- Anti-Thymocyte Globulins
- Globulin, Anti-Thymocyte
- Globulins, Anti-Thymocyte
Antilymphoblast Globulins- Antilymphoblast Globulins
- Antilymphoblast Globulin
- Globulin, Antilymphoblast
- Globulins, Antilymphoblast
Antilymphocyte Immunoglobulin- Antilymphocyte Immunoglobulin
- Antilymphocyte Immunoglobulins
- Immunoglobulin, Antilymphocyte
- Immunoglobulins, Antilymphocyte
|
Below are MeSH descriptors whose meaning is more general than "Antilymphocyte Serum".
Below are MeSH descriptors whose meaning is more specific than "Antilymphocyte Serum".
This graph shows the total number of publications written about "Antilymphocyte Serum" by people in this website by year, and whether "Antilymphocyte Serum" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 1 | 2 | 3 |
1996 | 2 | 2 | 4 |
1997 | 3 | 4 | 7 |
1998 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2001 | 2 | 0 | 2 |
2003 | 1 | 1 | 2 |
2004 | 0 | 1 | 1 |
2005 | 2 | 3 | 5 |
2006 | 1 | 0 | 1 |
2009 | 0 | 2 | 2 |
2015 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
2021 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antilymphocyte Serum" by people in Profiles.
-
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy. Transplant Cell Ther. 2021 12; 27(12):993.e1-993.e8.
-
Induction Therapy With Antithymocyte Globulin and Delayed Calcineurin Inhibitor Initiation for Renal Protection in Liver Transplantation: A Multicenter Randomized Controlled Phase II-B Trial. Transplantation. 2022 05 01; 106(5):997-1003.
-
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group. Transplantation. 2020 05; 104(5):911-922.
-
Association of medication non-adherence with short-term allograft loss after the treatment of severe acute kidney transplant rejection. BMC Nephrol. 2019 10 17; 20(1):373.
-
Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial. Biol Blood Marrow Transplant. 2018 11; 24(11):2216-2223.
-
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation. J Clin Oncol. 2017 Dec 20; 35(36):4003-4011.
-
Invasive fungal infection after heart transplantation: A 7-year, single-center experience. Transpl Infect Dis. 2017 Feb; 19(1).
-
Antithymocyte globulin for graft-versus-host disease prophylaxis: mistakenly maligned. Leuk Lymphoma. 2015 Apr; 56(4):841-2.
-
Serum sickness after treatment with rabbit antithymocyte globulin in a heart transplant recipient with previous rabbit exposure. Transplant Proc. 2015 Jan-Feb; 47(1):198-200.
-
Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients. Pediatr Transplant. 2014 Feb; 18(1):79-86.